{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:08:01Z","timestamp":1780628881776,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.14283\/jpad.2022.101","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T09:50:12Z","timestamp":1668678612000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)"],"prefix":"10.1016","volume":"10","author":[{"given":"Edmond","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Manser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pickthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Djakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Swendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Blendstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Faccin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ostrowitzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Sink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2022.101_bib1","doi-asserted-by":"crossref","first-page":"111c","DOI":"10.1126\/scitranslmed.3002609","article-title":"Testing the right target and right drug at the right stage","volume":"3","author":"Sperling","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.14283\/jpad.2022.101_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12603-010-0066-1","article-title":"The potential and limits for clinical trials for early Alzheimer's disease and some recommendations","volume":"14","author":"Schneider","year":"2010","journal-title":"J Nutr Health Aging"},{"key":"10.14283\/jpad.2022.101_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.14283\/jpad.2022.101_bib4","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0000000000002576","article-title":"Alzheimer's Disease Neuroimaging Initiative. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI","volume":"86","author":"Landau","year":"2016","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.101_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.dadm.2018.02.008","article-title":"Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients","volume":"10","author":"Tomadesso","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.14283\/jpad.2022.101_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3233\/JAD-122212","article-title":"Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpoints","volume":"36","author":"Macklin","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11682-018-0019-6","article-title":"Modifying the minimum criteria for diagnosing amnestic MCI to improve prediction of brain atrophy and progression to Alzheimer's disease","volume":"14","author":"Vuoksimaa","year":"2020","journal-title":"Brain Imaging Behav"},{"key":"10.14283\/jpad.2022.101_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/87565648709540361","article-title":"Genuine memory deficits in dementia","volume":"3","author":"Grober","year":"1987","journal-title":"Dev Neuropsychol"},{"key":"10.14283\/jpad.2022.101_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.14283\/jpad.2022.101_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.0b013e318245f447","article-title":"Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease","volume":"78","author":"Wagner","year":"2012","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.101_bib11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jalz.2016.12.014","article-title":"Free and Cued Selective Reminding Test \u2014 accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD)","volume":"13","author":"Teichmann","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.101_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.jagp.2019.08.012","article-title":"The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease","volume":"27","author":"Randolph","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"issue":"Suppl1","key":"10.14283\/jpad.2022.101_bib13","first-page":"S19","article-title":"FCSRT inclusion criteria support recruitment of a population with early Alzheimer's disease likely to progress over 24 months: Results from the CREAD trial","volume":"6","author":"Sink","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3233\/JAD-190950","article-title":"The role of free and cued selective reminding test in predicting [18F]Florbetaben PET results in mild cognitive impairment and mild dementia","volume":"73","author":"Spallazzi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/13803395.2021.2023476","article-title":"Predicting biomarkers in intact older adults and those with amnestic Mild Cognitive Impairment, and mild Alzheimer's Disease using the Repeatable Battery for the Assessment of Neuropsychological Status","volume":"43","author":"Suhrie","year":"2021","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.14283\/jpad.2022.101_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2022.2909","article-title":"Evaluating the safety and efficacy of crenezumab vs placebo in adults with early Alzheimer disease: Two Phase 3 randomized placebo-controlled trials","author":"Ostrowitski","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2022.101_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2022.1375","article-title":"Safety and efficacy of semorinemab in individuals with prodromal to mild Alzheimer's disease: A randomized clinical trial","author":"Teng","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.14283\/jpad.2022.101_bib18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.101_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.101_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.14283\/jpad.2022.101_bib21","author":"Imaging"},{"key":"10.14283\/jpad.2022.101_bib22","author":"Healthcare G"},{"key":"10.14283\/jpad.2022.101_bib23","author":"Lilly"},{"key":"10.14283\/jpad.2022.101_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces (18)F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2022.101_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.14283\/jpad.2022.101_bib26","first-page":"P343","article-title":"Free and Cued Selective Reminding Test as an inclusion criterion for early Alzheimer's disease clinical trial populations","volume":"3","author":"Smith","year":"2016","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","article-title":"Free and cued selective reminding identifies very mild dementia in primary care","volume":"24","author":"Grober","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2022.101_bib28","series-title":"Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Manual","author":"Randolph C","year":"1998"},{"key":"10.14283\/jpad.2022.101_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14283\/jpad.2020.73","article-title":"Psychometric properties of the clinical dementia rating \u2014 sum of boxes and other cognitive and functional outcomes in a prodromal Alzheimer's disease population","volume":"8","author":"McDougall","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/13803390490918363","article-title":"Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample","volume":"27","author":"Duff","year":"2005","journal-title":"J Clin Exp Neuropsychol"},{"issue":"Suppl 2","key":"10.14283\/jpad.2022.101_bib31","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 2","key":"10.14283\/jpad.2022.101_bib32","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.14283\/jpad.2022.101_bib33","author":"Team RC"},{"key":"10.14283\/jpad.2022.101_bib34","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10072-015-2237-7","article-title":"A normative study of the Italian printed word version of the Free and Cued Selective Reminding Test","volume":"36","author":"Girtler","year":"2015","journal-title":"Neurol Sci"},{"key":"10.14283\/jpad.2022.101_bib35","first-page":"S012","article-title":"Clinical and amyloid screen failure rates in episodic memory measures in early AD trials","volume":"5","author":"Negash","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.101_bib37","doi-asserted-by":"crossref","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of beta-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Commun"},{"key":"10.14283\/jpad.2022.101_bib38","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.14283\/jpad.2022.101_bib39","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1212\/01.wnl.0000279336.36610.f7","article-title":"Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study","volume":"69","author":"Sarazin","year":"2007","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.101_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13195-020-00595-5","article-title":"Elecsys CSF biomarker immunoassays demonstrate concordance with amyloid-PET imaging","volume":"12","author":"Doecke","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2022.101_bib41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid analysis detects cerebral amyloid-beta accumulation earlier than positron emission tomography","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"key":"10.14283\/jpad.2022.101_bib42","first-page":"S50","article-title":"Phase 2 study of tilavonemab, an anti-tau antibody, in early Alzheimer's disease","volume":"8","author":"Florian","year":"2021","journal-title":"J Prev Alzheimers Dis"},{"key":"10.14283\/jpad.2022.101_bib43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, Phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2022.101_bib44","first-page":"S65","article-title":"Top-line results from TANGO, a Phase 2 study of gosuranemab in participants with mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease","volume":"8","author":"Shulman","year":"2021","journal-title":"J Prev Alzheimers Dis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:11:03Z","timestamp":1737339063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2274580724002486"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.101","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}